Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Emily S Gorell

TitleAssistant Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-DERM General Operations

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Pathmarajah P, Eid E, Nazaroff J, So J, Mittal V, Harris N, Li S, Lucky AW, Gorell ES, Peoples KG, Pope E, Lara-Corrales I, Paller AS, Wiss K, Perman MJ, Eichenfield LF, Levy ML, Morel KD, Garc?a-Romero MT, McCuaig CC, Saber M, Marinkovich MP, Oro A, Bruckner AL, Tang JY. Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa. Br J Dermatol. 2025 Apr 28; 192(5):917-925. PMID: 39790012.
      View in: PubMed
    2. Sabharwal K, Blanchard I, Gorell ES, Iqneibi M, Lucky AW, Worhunsky DJ. Junctional Epidermolysis Bullosa With Pyloric Atresia Complicated by Esophageal Atresia and Nephrotic Syndrome: A Case Report and Review of the Literature. Pediatr Dermatol. 2025 Mar 03. PMID: 40033822.
      View in: PubMed
    3. Mackenzie E, Lucky AW, Gorell ES. A call to action to address transition of care in pediatric dermatology. Pediatr Dermatol. 2024 Nov-Dec; 41(6):1121-1122. PMID: 39563639.
      View in: PubMed
    4. Okata-Karigane U, Pathmarajah P, Gorell ES, Sum K, Yekrang K, Phung M, Barriga M, Udrizar P, Bailey I, Li S, Lu Y, Tang JY, Chiou AS. Evaluation of antipruritic effects of serlopitant, a neurokinin 1?receptor antagonist, in patients with epidermolysis bullosa: A?phase 2 randomized controlled trial. J Eur Acad Dermatol Venereol. 2025 Mar; 39(3):e215-e217. PMID: 38949042.
      View in: PubMed
    5. So JY, Nazaroff J, Yenamandra VK, Gorell ES, Harris N, Fulchand S, Eid E, Dolorito JA, Marinkovich MP, Tang JY. Functional genotype-phenotype associations in recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol. 2024 Sep; 91(3):448-456. PMID: 38735484.
      View in: PubMed
    6. Iqneibi M, Gorell ES, Lucky AW. To prevent pain and anxiety, culture samples may be obtained from wound dressings. Pediatr Dermatol. 2024 May-Jun; 41(3):563-564. PMID: 38743451.
      View in: PubMed
    7. Abreu Molnar B, Levin L, Yun D, Morel K, Wiss K, Wieser J, Ward C, Trice H, Garcia-Romero MT, Stephenson A, Provost A, Price HN, Perman MJ, Moxon M, Moeves B, McCuaig CC, McCarthy C, Lucky AW, Levy ML, Lee M, Lara-Corrales I, Henner N, Halliburton N, Griffith E, Gorell E, Glick S, Eichenfield L, Collins C, Bruckner AL, Boulrice B, Bayliss S, Badger K, Paller AS. Inpatient management of epidermolysis bullosa: Consensus-based hands-on instructions for neonates and postneonates. J Am Acad Dermatol. 2024 Aug; 91(2):290-299. PMID: 38604489.
      View in: PubMed
    8. Singh A, Gorell ES, Lucky AW. Topical everolimus therapy for epidermal nevi associated with woolly hair nevus in a patient with a mosaic HRAS mutation. Pediatr Dermatol. 2024 Sep-Oct; 41(5):871-873. PMID: 38558293.
      View in: PubMed
    9. Rangu S, Collins J, Garc?a-Romero MT, Augsburger BD, Bruckner AL, Diaz LZ, Eichenfield LF, Faig W, Gorell ES, Lefferdink R, Lucky AW, Morel KD, Paller AS, Park H, Pastrana-Arellano E, Peoples K, Wiss K, Perman MJ, Castelo-Soccio L. Assessing pain catastrophizing and functional disability in pediatric epidermolysis bullosa patients. Pediatr Dermatol. 2023 May-Jun; 40(3):422-427. PMID: 36579717.
      View in: PubMed
    10. So JY, Nazaroff J, Iwummadu CV, Harris N, Gorell ES, Fulchand S, Bailey I, McCarthy D, Siprashvili Z, Marinkovich MP, Tang JY, Chiou AS. Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa. Orphanet J Rare Dis. 2022 10 17; 17(1):377. PMID: 36253825.
      View in: PubMed
    11. Aggarwal P, Gorell ES, Flood KS, Spicknall K, Breneman D. An uncommon presentation of cutaneous dissemination of gout. JAAD Case Rep. 2023 Jan; 31:89-92. PMID: 36545484.
      View in: PubMed
    12. Betancourt NJ, Sum K, Gorell ES, Tang JY, Chiou AS. Asymptomatic, microscopic hematuria in epidermolysis bullosa: A single center retrospective case series. J Am Acad Dermatol. 2022 12; 87(6):1419-1421. PMID: 36007691.
      View in: PubMed
    13. So JY, Fulchand S, Wong CY, Li S, Nazaroff J, Gorell ES, de Souza MP, Murrell DF, Teng JM, Chiou AS, Tang JY. A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex. Orphanet J Rare Dis. 2022 07 15; 17(1):270. PMID: 35841105.
      View in: PubMed
    14. Fulchand S, Harris N, Li S, Barriga M, Gorell E, De Souza M, Murrell D, Marinkovich MP, Krishna Yenamandra V, Tang JY. Patient-reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: A global cross-sectional survey. Pediatr Dermatol. 2021 Sep; 38(5):1198-1201. PMID: 34515355.
      View in: PubMed
    15. Schr?der NHB, Gorell ES, Stewart RE, Duipmans JC, Harris N, Perez VA, Tang JY, Wolff AP, Bolling MC. Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study. Orphanet J Rare Dis. 2021 09 06; 16(1):377. PMID: 34488820.
      View in: PubMed
    16. Lucky AW, Whalen J, Rowe S, Marathe KS, Gorell E. Diagnosis and Care of the Newborn with Epidermolysis Bullosa. Neoreviews. 2021 07; 22(7):e438-e451. PMID: 34210808.
      View in: PubMed
    17. Tang JY, Marinkovich MP, Lucas E, Gorell E, Chiou A, Lu Y, Gillon J, Patel D, Rudin D. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa. Orphanet J Rare Dis. 2021 04 13; 16(1):175. PMID: 33849616.
      View in: PubMed
    18. Solis DC, Gorell ES, Teng C, Barriga M, Nazaroff J, Li S, Subica A, Lu Y, Marinkovich MP, Tang JY. Clinical characteristics associated with increased wound size in patients with recessive dystrophic epidermolysis bullosa. Pediatr Dermatol. 2021 May; 38(3):704-706. PMID: 33749033.
      View in: PubMed
    19. Gorell ES, Wolstencroft PW, de Souza MP, Murrell DF, Linos E, Tang JY. Financial burden of epidermolysis bullosa on patients in the United States. Pediatr Dermatol. 2020 Nov; 37(6):1198-1201. PMID: 32897588.
      View in: PubMed
    20. Solis DC, Teng C, Gorell ES, Barriga M, Nazaroff J, Li S, Lu Y, Bruckner A, Marinkovich MP, Tang JY. Classification of 2 distinct wound types in recessive dystrophic epidermolysis bullosa: A retrospective and cohort natural history study. J Am Acad Dermatol. 2021 11; 85(5):1296-1298. PMID: 32896597.
      View in: PubMed
    21. Khaddour K, Gorell ES, Dehdashti F, Tang JY, Ansstas G. Induced Remission of Metastatic Squamous Cell Carcinoma with an Immune Checkpoint Inhibitor in a Patient with Recessive Dystrophic Epidermolysis Bullosa. Case Rep Oncol. 2020 May-Aug; 13(2):911-915. PMID: 32884539.
      View in: PubMed
    22. Eng VA, Solis DC, Gorell ES, Choi S, Nazaroff J, Li S, de Souza MP, Murrell DF, Marinkovich MP, Tang JY. Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional survey. J Am Acad Dermatol. 2021 11; 85(5):1161-1167. PMID: 32199895.
      View in: PubMed
    23. Eichstadt S, Barriga M, Ponakala A, Teng C, Nguyen NT, Siprashvili Z, Nazaroff J, Gorell ES, Chiou AS, Taylor L, Khuu P, Keene DR, Rieger K, Khosla RK, Furukawa LK, Lorenz HP, Marinkovich MP, Tang JY. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa. JCI Insight. 2019 10 03; 4(19). PMID: 31578311.
      View in: PubMed
    24. Siprashvili Z, Nguyen NT, Gorell ES, Loutit K, Khuu P, Furukawa LK, Lorenz HP, Leung TH, Keene DR, Rieger KE, Khavari P, Lane AT, Tang JY, Marinkovich MP. Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa. JAMA. 2016 Nov 01; 316(17):1808-1817. PMID: 27802546.
      View in: PubMed
    25. Gorell ES, Nguyen N, Siprashvili Z, Marinkovich MP, Lane AT. Characterization of patients with dystrophic epidermolysis bullosa for collagen VII therapy. Br J Dermatol. 2015 Sep; 173(3):821-3. PMID: 25703736.
      View in: PubMed
    26. Danial C, Adeduntan R, Gorell ES, Lucky AW, Paller AS, Bruckner AL, Pope E, Morel KD, Levy ML, Li S, Gilmore ES, Lane AT. Evaluation of Treatments for Pruritus in Epidermolysis Bullosa. Pediatr Dermatol. 2015 Sep-Oct; 32(5):628-34. PMID: 25557557.
      View in: PubMed
    27. Gorell ES, Leung TH, Khuu P, Lane AT. Purified type I collagen wound matrix improves chronic wound healing in patients with recessive dystrophic epidermolysis bullosa. Pediatr Dermatol. 2015 Mar-Apr; 32(2):220-5. PMID: 25557742.
      View in: PubMed
    28. Danial C, Adeduntan R, Gorell ES, Lucky AW, Paller AS, Bruckner A, Pope E, Morel KD, Levy ML, Li S, Gilmore ES, Lane AT. Prevalence and characterization of pruritus in epidermolysis bullosa. Pediatr Dermatol. 2015 Jan-Feb; 32(1):53-9. PMID: 25236506.
      View in: PubMed
    29. Gorell E, Nguyen N, Lane A, Siprashvili Z. Gene therapy for skin diseases. Cold Spring Harb Perspect Med. 2014 Apr 01; 4(4):a015149. PMID: 24692191.
      View in: PubMed
    30. Spitale RC, Cheng MY, Chun KA, Gorell ES, Munoz CA, Kern DG, Wood SM, Knaggs HE, Wulff J, Beebe KD, Chang AL. Differential effects of dietary supplements on metabolomic profile of smokers versus non-smokers. Genome Med. 2012 Feb 23; 4(2):14. PMID: 22360970.
      View in: PubMed
    31. Sbicca JA, Gorell ES, Peng DH, Lane AT. A follow-up survey of the integrity of the dermatology National Resident Matching Program. J Am Acad Dermatol. 2012 Sep; 67(3):429-35. PMID: 22088426.
      View in: PubMed
    32. Gorell ES, Tichy AL, Lane AT. Successful investigational new drug preparation without reinventing the wheel. J Invest Dermatol. 2011 May; 131(5):996-8. PMID: 21494234.
      View in: PubMed
    33. Sbicca JA, Gorell ES, Kanzler MH, Lane AT. The integrity of the dermatology National Resident Matching Program: results of a national study. J Am Acad Dermatol. 2010 Oct; 63(4):594-601. PMID: 20599295.
      View in: PubMed
    34. Fong KD, Hu D, Eichstadt SL, Gorell E, Munoz CA, Lorenz HP, Chang AL. ??????Initial clinical experience using a novel ultraportable negative pressure wound therapy device. Wounds. 2010 Sep; 22(9):230-6. PMID: 25901554.
      View in: PubMed
    35. Barreto-Chang OL, Gorell ES, Yamaguma MA, Lane AT. Diagnosis of pilomatricoma using an otoscope. Pediatr Dermatol. 2010 Sep-Oct; 27(5):554-7. PMID: 20807359.
      View in: PubMed
    36. Janjua R, Munoz C, Gorell E, Rehmus W, Egbert B, Kern D, Chang AL. A two-year, double-blind, randomized placebo-controlled trial of oral green tea polyphenols on the long-term clinical and histologic appearance of photoaging skin. Dermatol Surg. 2009 Jul; 35(7):1057-65. PMID: 19469799.
      View in: PubMed
    37. Gorell E, Lee C, Mu?oz C, Chang AL. Adoption of Western culture by Californian Asian Americans: attitudes and practices promoting sun exposure. Arch Dermatol. 2009 May; 145(5):552-6. PMID: 19451499.
      View in: PubMed
    Gorell's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (125) concept(s)
    _
    Co-Authors Expand Description
    See all (1) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)